Speciation 98: Abstracts
Lage Pettersson, Ingegärd Andersson and Sarah Angus-Dunne
Department of Inorganic Chemistry, Umeå University, SE-901 87 Umeå, Sweden
Peroxovanadates have recently received wide attention due to their biochemical significance, most notably insulin-mimetic behavior.1 Although there have been several speciation studies performed on vandate-peroxo systems,2-4 no pH independent formation constants have been reported. A detailed and thorough potentiometric (glass electrode) and 51V NMR (Bruker AMX-500 MHz) spectroscopic investigation of the H+-H2VO4--H2O2 system has therefore been performed (25 C, 0.15 M Na(Cl)). This medium was chosen to represent physiological conditions and an extensive pH (0.5-10.5) and vanadate concentration range (1-80 mM) was covered. The computer program LAKE,5 designed to simultaneously treat multimethod data, has been used to establish the entire speciation in the system.
Peroxide interacts with vanadate in the whole pH range studied and equilibration is fast, except when initially formed decavanadates slowly decompose. Six major complexes were found, VX2-, VX2-, VX22-, VX32-, V2X43- and VX+ (X = peroxo ligand) and three minor complexes, V2X3- and two isomeric V2X23- species, which are only observed in the pH range 7-10 at high Vtot concentrations. The species are strongly dependent on the H2O2/V ratio as shown in the figure (Vtot = 20 mM, pH = 8.1). The VX2- species is only present at low ratios (cf. lower spectrum). However, under such conditions a substantial amount of vanadium has not reacted with peroxide. The four larger peaks to the left represent mono-, di-, tetra- and pentameric vanadate species and the small peaks originate from the minor vanadoperoxide species. The VX2n- species are "strong" and at H2O2/V = 2 (middle spectrum) all vanadium is bound in peroxo species. The VX32- species becomes predominant at excess of peroxide (upper spectrum). The VX+ species occurs as a predominant species but only at low pH.
Formation constants will be given for all species and the equilibrium conditions illustrated in distribution diagrams. Structural aspects will be discussed. Some preliminary results from the vanadoperoxoimidazole system will also be presented.
References